Hjem › Graft-versus-host-sykdom › Massachusetts › Boston
Kliniske studier for Graft-versus-host-sykdom i Boston, MA
10 studier for Graft-versus-host-sykdom søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Rekrutterer
- Massachusetts General Hospital, Boston
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RekruttererFase 2
- Massachusetts General Hospital, Boston
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RekruttererFase 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
RekruttererFase 2
- Boston Children's Hospital, Boston
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
Rekrutterer
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RekruttererFase 2
- Dana-Farber Cancer Institute, Boston
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
RekruttererObservasjonsstudie
- Dana Farber, Boston
IS-free Treg HaploHCT
RekruttererFase 1
- Dana Farber Cancer Institute, Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
Graft-versus-host-sykdom-studier i andre byer
- New York City, NY7 studier
- Columbus, OH6 studier
- Atlanta, GA5 studier
- Washington, DC5 studier
- Portland, OR4 studier
- Pittsburgh, PA4 studier
- Baldwin Park, CA4 studier
- Tampa, FL4 studier
- St. Louis, MO4 studier
- Detroit, MI4 studier
- Miami, FL4 studier
- Queens, NY4 studier
Andre studier i Boston
- Brystkreft111 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)86 studier
- Kolorektal kreft63 studier
- Metastatisk kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.